Risk Stratification of Pulmonary Embolism

Thomas Moumneh, Philip S. Wells, Sebastien Miranda

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Given the broad treatment options, risk stratification of pulmonary embolism is a highly desirable component of management. The ideal tool identifies patients at risk of death from the original or recurrent pulmonary embolism. Using all-cause death in the first 30-days after pulmonary embolism diagnosis as a surrogate, clinical parameters, biomarkers, and radiologic evidence of right ventricular dysfunction and strain are predictive. However, no study has demonstrated improved mortality rates after implementation of a risk stratification strategy to guide treatment. Further research should use better methodology to study prognosis and test new management strategies in patients at high risk for death.

Original languageEnglish
Pages (from-to)437-448
Number of pages12
JournalCritical Care Clinics
Issue number3
StatePublished - Jul 2020
Externally publishedYes


  • Biomarkers
  • Clinical assessment
  • Mortality
  • Prognosis
  • Pulmonary embolism
  • Risk stratification


Dive into the research topics of 'Risk Stratification of Pulmonary Embolism'. Together they form a unique fingerprint.

Cite this